Generation of a homozygous CPAMD8 knockout human embryonic stem cell line (WAe009-A-2R) by CRISPR/Cas9 system

被引：0
|
作者：
Pan, Wenmin [1 ,2 ,3 ]
Yang, Yuhe [2 ]
Zhang, Shun [1 ,2 ,3 ]
Liu, Xiaoyu [2 ]
Hu, Huijuan [2 ]
Qu, Jia [1 ,2 ,3 ,4 ]
Liu, Hui [2 ,4 ]
机构：
[1] Hainan Univ, Sch Biomed Engn, Haikou, Hainan, Peoples R China
[2] Wenzhou Med Univ, Eye Hosp, Natl Engn Res Ctr Ophthalmol & Optometry, Wenzhou, Peoples R China
[3] Hainan Inst Real World Data, Qionghai, Peoples R China
[4] Zhejiang Lab Regenerat Med Vis & Brain Hlth, Oujiang Lab, Wenzhou, Peoples R China
来源：
STEM CELL RESEARCH | 2025年 / 84卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.scr.2025.103683
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
CPAMD8, a constituent of the A2M/C3 (alpha-2-macroglobulin/complement 3) protein family, is strikingly expressed in the human fetal lens and distal neural retina. Mutations in CPAMD8 have been linked to anterior segment dysgenesis and primary congenital glaucoma. We utilized CRISPR/Cas9 technology to establish a homozygous CPAMD8 knockout human embryonic stem cell line for differentiating retinal organoids, with the intent of exploring the role of CPAMD8 in the early development of the human eye. The CPAMD8 knockout cell line exhibits normal morphology, pluripotency, and karyotype, serving as a valuable research tool for investigating the functions of CPAMD8 in ophthalmology.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Generation of a homozygous LRP2 knockout human embryonic stem cell line (FDCHDPe010-A-56) by CRISPR/Cas9 system
    You, Jie
    Cheng, Yun
    Yang, Xian-Jie
    Chen, Ling
    STEM CELL RESEARCH, 2021, 53
  • [32] Generation of an Abcc8 homozygous mutation human embryonic stem cell line using CRISPR/Cas9
    Guo, Dongsheng
    Liu, Haikun
    Gao, Ge
    Ruzi, Aynisahan
    Wang, Kepin
    Wu, Han
    Lai, Keyu
    Liu, Yanli
    Yang, Fan
    Lai, Liangxue
    Li, Yin-xiong
    STEM CELL RESEARCH, 2016, 17 (03) : 640 - 642
  • [33] Establishment of a PPP2CA homozygous knockout human embryonic stem cell line via CRISPR/Cas9 system
    Ding, Tongbin
    Gao, Zhe
    Liu, Hang
    Li, Yuan
    Liu, Shichao
    Jian, Liguo
    STEM CELL RESEARCH, 2023, 67
  • [34] Generating an MEIS1 homozygous knockout human embryonic stem cell line using the CRISPR/Cas9 system
    Zhang, Canwei
    Yu, Yankun
    Li, Fuxi
    Lan, Xihong
    Wang, Li
    STEM CELL RESEARCH, 2020, 49
  • [35] Generation of a TBX20-knockout human embryonic stem line by CRISPR/Cas9 system
    Wu, Xiaodan
    Wang, Xiantao
    STEM CELL RESEARCH, 2023, 69
  • [36] Generation of a Bag1 homozygous knockout mouse embryonic stem cell line using CRISPR/Cas9
    Tang, Cheng-cheng
    Shan, Li Pik
    Wang, Wu-ming
    Lu, Gang
    Tare, Rahul S.
    Lee, Kenneth Ka Ho
    STEM CELL RESEARCH, 2017, 21 : 29 - 31
  • [37] Generation of a COL1A2 homozygous knockout stem cell line via CRISPR/Cas9 system
    Ma, Shuhong
    Saleem, Amina
    Li, Xiaowei
    Lu, Wen-Jing
    Jiang, Hongfeng
    STEM CELL RESEARCH, 2022, 59
  • [38] Generation of a homozygous P4HA2 knockout human embryonic stem cell line (FDCHDPe012-A) by CRISPR/Cas9 system
    You, Jie
    Ma, Shuangping
    Zhang, Haokun
    Chen, Ling
    STEM CELL RESEARCH, 2022, 64
  • [39] Generation of an ASS1 heterozygous knockout human embryonic stem cell line, WAe001-A-13, using CRISPR/Cas9
    Yuan, Fang
    Guo, Dongsheng
    Liu, Yanli
    Xu, Yingying
    Gao, Ge
    Wu, Yuhang
    Yang, Fan
    Ke, Xinrong
    Lai, Keyu
    Wei, Hongcheng
    Li, Yin-Xiong
    STEM CELL RESEARCH, 2018, 26 : 67 - 71
  • [40] Generation of a NONO homozygous knockout human induced pluripotent stem cell line by CRISPR/Cas9 editing
    Yi, Tong
    Bai, Rui
    Sun, Hairui
    Lan, Feng
    Zhang, Hongjia
    He, Yihua
    STEM CELL RESEARCH, 2020, 47
12345